Market Overview:
The global complex percutaneous coronary intervention (PCI) market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of cardiovascular diseases, technological advancements in PCI devices, and rising geriatric population. Based on type, the global complex PCI market is segmented into drug-eluting stents (DES), bare metal stents, and bioresorbable stents. DES held the largest share of the global complex PCI market in 2017 and is expected to maintain its dominance during the forecast period. This can be attributed to their superior efficacy as compared to other types of stents available in the market. Based on application,the global complex PCImarket is segmented into percutaneous coronary intervention (PCI), transcatheter aortic valve implantation (TAVI/TAVR),and trans-mitral valve implantation(TMVR).
Product Definition:
A complex percutaneous coronary intervention (PCI) is a procedure used to open blocked or narrowed coronary arteries. This type of PCI usually involves the use of a heart catheter to deliver medication or devices such as stents to the affected artery. Complex PCI may also be referred to as high-risk PCI, bailout PCI, or rescue PCI.
Drug-Eluting Stents (DES):
A drug-eluting stent is a device that is used to prevent the reoccurrence of coronary artery disease. The DES are made up of biocompatible materials such as polymers and have an attached bioactive agent which helps in reducing the inflammation caused by atherosclerotic plaques.
The introduction of novel drug-eluting stents has led to improved patient outcomes, reduced hospitalization,.
Bare Metal Stents:
Bare metal stents are used in complex percutaneous coronary intervention (PCI) procedures. They are placed by the interventional cardiologists to open a blocked artery and allow blood flow. The bare metal stent was first approved by the U.
Application Insights:
The transcatheter aortic valve implantation segment dominated the global complex percutaneous coronary intervention market in 2017. This is owing to factors such as increasing prevalence of aortic stenosis and other cardiovascular diseases, growing geriatric population, and technological advancements for valve replacement procedures. Moreover, there are various ongoing clinical trials for percutaneous aortic valves that will further boost product demand in near future.
PCI held the largest share of 29% in 2017 due to factors such as rising awareness about early diagnosis and treatment of PCI-related complications along with an increase in number of PCI procedures performed annually worldwide. According to estimates published by ELSO, around 1 million coronary interventions were performed globally during 2016-2017 period; this was an increase from previous year when 870 thousand were performed during 2015-2016 period.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to factors such as favorable reimbursement policies, increasing prevalence of cardiovascular diseases, and presence of major players in the region. Moreover, growing awareness about PCI procedures and availability of highly skilled physicians are some other factors contributing toward regional growth.
, which increases susceptibility towards heart diseases & cardiac arrests. In addition, improving healthcare infrastructure coupled with economic development will boost demand for percutaneous coronary interventions in this region over the forecast period.
Growth Factors:
- Increasing incidence of coronary artery diseases (CAD) due to changing lifestyle and unhealthy eating habits.
- Rising geriatric population with increasing prevalence of CAD.
- Technological advancements in the field of PCI that are making the procedure safer and more efficient.
- Growing demand for minimally invasive procedures for treatment of CADs.
Scope Of The Report
Report Attributes
Report Details
Report Title
Complex Percutaneous Coronary Intervention Market Research Report
By Type
Drug-Eluting Stents (DES), Bare Metal Stents, Bioresorbable Stents
By Application
Percutaneous Coronary Intervention (PCI), Transcatheter Aortic Valve Implantation (TAVI/TAVR), Trans-Mitral Valve Implantation (TMVR)
By Companies
Abbott Laboratories, Medtronic, Boston Scientific, B. Braun Melsungen, Biosensors International, Biotronik, Terumo, Johnson & Johnson, Getinge, Abbott
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
129
Number of Tables & Figures
91
Customization Available
Yes, the report can be customized as per your need.
Global Complex Percutaneous Coronary Intervention Market Report Segments:
The global Complex Percutaneous Coronary Intervention market is segmented on the basis of:
Types
Drug-Eluting Stents (DES), Bare Metal Stents, Bioresorbable Stents
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Percutaneous Coronary Intervention (PCI), Transcatheter Aortic Valve Implantation (TAVI/TAVR), Trans-Mitral Valve Implantation (TMVR)
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories
- Medtronic
- Boston Scientific
- B. Braun Melsungen
- Biosensors International
- Biotronik
- Terumo
- Johnson & Johnson
- Getinge
- Abbott
Highlights of The Complex Percutaneous Coronary Intervention Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Drug-Eluting Stents (DES)
- Bare Metal Stents
- Bioresorbable Stents
- By Application:
- Percutaneous Coronary Intervention (PCI)
- Transcatheter Aortic Valve Implantation (TAVI/TAVR)
- Trans-Mitral Valve Implantation (TMVR)
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Complex Percutaneous Coronary Intervention Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Complex percutaneous coronary intervention (CPI) is a type of angioplasty that uses a catheter to open up an artery in the heart. The procedure is used to treat blocked arteries in the heart.
Some of the major players in the complex percutaneous coronary intervention market are Abbott Laboratories, Medtronic, Boston Scientific, B. Braun Melsungen, Biosensors International, Biotronik, Terumo, Johnson & Johnson, Getinge, Abbott.
The complex percutaneous coronary intervention market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Complex Percutaneous Coronary Intervention Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Complex Percutaneous Coronary Intervention Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Complex Percutaneous Coronary Intervention Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Complex Percutaneous Coronary Intervention Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Complex Percutaneous Coronary Intervention Market Size & Forecast, 2020-2028
4.5.1 Complex Percutaneous Coronary Intervention Market Size and Y-o-Y Growth
4.5.2 Complex Percutaneous Coronary Intervention Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Drug-Eluting Stents (DES)
5.2.2 Bare Metal Stents
5.2.3 Bioresorbable Stents
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Percutaneous Coronary Intervention (PCI)
6.2.2 Transcatheter Aortic Valve Implantation (TAVI/TAVR)
6.2.3 Trans-Mitral Valve Implantation (TMVR)
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Complex Percutaneous Coronary Intervention Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Complex Percutaneous Coronary Intervention Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Drug-Eluting Stents (DES)
9.6.2 Bare Metal Stents
9.6.3 Bioresorbable Stents
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Percutaneous Coronary Intervention (PCI)
9.10.2 Transcatheter Aortic Valve Implantation (TAVI/TAVR)
9.10.3 Trans-Mitral Valve Implantation (TMVR)
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Drug-Eluting Stents (DES)
10.6.2 Bare Metal Stents
10.6.3 Bioresorbable Stents
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Percutaneous Coronary Intervention (PCI)
10.10.2 Transcatheter Aortic Valve Implantation (TAVI/TAVR)
10.10.3 Trans-Mitral Valve Implantation (TMVR)
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Drug-Eluting Stents (DES)
11.6.2 Bare Metal Stents
11.6.3 Bioresorbable Stents
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Percutaneous Coronary Intervention (PCI)
11.10.2 Transcatheter Aortic Valve Implantation (TAVI/TAVR)
11.10.3 Trans-Mitral Valve Implantation (TMVR)
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Drug-Eluting Stents (DES)
12.6.2 Bare Metal Stents
12.6.3 Bioresorbable Stents
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Percutaneous Coronary Intervention (PCI)
12.10.2 Transcatheter Aortic Valve Implantation (TAVI/TAVR)
12.10.3 Trans-Mitral Valve Implantation (TMVR)
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Drug-Eluting Stents (DES)
13.6.2 Bare Metal Stents
13.6.3 Bioresorbable Stents
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Percutaneous Coronary Intervention (PCI)
13.10.2 Transcatheter Aortic Valve Implantation (TAVI/TAVR)
13.10.3 Trans-Mitral Valve Implantation (TMVR)
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Complex Percutaneous Coronary Intervention Market: Competitive Dashboard
14.2 Global Complex Percutaneous Coronary Intervention Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott Laboratories
14.3.2 Medtronic
14.3.3 Boston Scientific
14.3.4 B. Braun Melsungen
14.3.5 Biosensors International
14.3.6 Biotronik
14.3.7 Terumo
14.3.8 Johnson & Johnson
14.3.9 Getinge
14.3.10 Abbott
